- Gaudium IVF IPO received 0.88 times subscription on the first day of bidding
- Retail investors subscribed 1.37 times, QIBs did not apply on day one
- Grey market shares traded at 11% premium over IPO price on second day
The initial public offering (IPO) of Gaudium IVF and Women Health Ltd. witnessed a lukewarm response from investors on the first day of bidding on Friday, Feb. 20. The mainboard issue was overall subscribed 0.88 times.
Gaudium IVF and Women Health, a Delhi-based In Vitro Fertilisation (IVF) treatment provider, aims to raise Rs 165 crore from the primary market through its IPO.
On the second day of subscription, in the grey market, the shares are currently trading at a premium of nearly 11% over the IPO price. The IPO has been subscribed 1.37 times so far on Monday
Here's a look at the latest grey market premium (GMP), subscription, price band and other key details about Gaudium IVF and Women Health IPO.
Gaudium IVF IPO GMP
The grey market premium for the Gaudium IVF IPO stood at Rs 8.5 per share on Feb. 23. Compared to the upper limit of the issue price of Rs 79 apiece, the latest GMP indicates an estimated listing price of Rs 87.5 at a premium of 10.76% per share.
Note: GMP does not represent official data and is based on speculation.
Also Read What Does Clean Max Enviro Energy IPO GMP Signals On Day 1 Of Subscription; Check Key Details
Gaudium IVF IPO: All You Need To Know
The Gaudium IVF IPO received bids for 1,28,56,347 shares compared to 1,46,20,340 shares on offer on the first day of bidding, leading to an overall subscription of 0.88 times. The IPO subscription was driven by retail investors, who booked their quota 1.37 times. The Non-Institutional Investors' (NIIs) category was subscribed 0.91 times, while the Qualified Institutional Buyers' (QIBs) category did not receive any applications on the first day.
Gaudium IVF IPO comprises a fresh issue of 1.14 crore shares, amounting to Rs 90 crore and an offer-for-sale (OFS) portion of 95 lakh shares, worth Rs 75 crore. The IPO price band has been fixed at Rs 75 to Rs 79 per share.
The retail investors can participate in the Gaudium IVF IPO subscription by applying for at least a single lot size of 189 shares, amounting to a minimum investment of Rs 14,931. For the small NIIs, the minimum application size is 14 lots, worth Rs 2,09,034. The big NIIs are required to apply for at least 67 lots, aggregating to a minimum investment of Rs 10,00,377.
The subscription window for the Gaudium IVF IPO will remain open till Feb. 24. The company is expected to finalise the IPO share allotment status on Feb. 25. Refunds for the non-allottees will also be processed on the same day.
The listing date for the Gaudium IVF IPO has been tentatively fixed as Feb. 27. Shares of the Gaudium IVF and Women Health Ltd. will be listed on the NSE and BSE.
Gaudium IVF and Women Health has proposed to use the IPO funds for the establishment of new IVF centres, repayment of debts and general corporate purposes.
About Gaudium IVF and Women Health
Gaudium IVF and Women Health Ltd, incorporated in 2015, provides fertility services through its centres across multiple cities in India. The company currently provides its services across thirty locations in India. The company operates two centres in Delhi and one each in Bengaluru, Mumbai, Ludhiana, Patna and Srinagar.
Disclaimer: Investments in initial public offerings are subject to market risks. Please consult with financial advisors and read the red herring prospectus thoroughly before placing bids.
ALSO READ: Check Shree Ram Twistex IPO GMP As Mainboard IPO Opens For Subscription
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.